CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

NitazoxanideWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (8)

Name (Synonyms) Correlation
drug612 Ivermectin Wiki 0.71
drug262 Chloroquine Wiki 0.65
drug802 Other drugs Wiki 0.58
drug1148 Therapeutic Anticoagulation Wiki 0.58
drug1343 modification of the planned therapeutic management Wiki 0.58
drug749 Niclosamide Wiki 0.41
drug431 Favipiravir Wiki 0.18
drug108 Azithromycin Wiki 0.11

Correlated MeSH Terms (11)

Name (Synonyms) Correlation
D001943 Breast Neoplasms NIH 0.58
D010051 Ovarian Neoplasms NIH 0.58
D014846 Vulvar Neoplasms NIH 0.58
D002583 Uterine Cervical Neoplasms NIH 0.58
D014594 Uterine Neoplasms NIH 0.58
D014625 Vaginal Neoplasms NIH 0.58
D020141 Hemostatic Disorders NIH 0.29
D001778 Blood Coagulation Disorders NIH 0.29
D009369 Neoplasms, NIH 0.17
D045169 Severe Acute Respiratory Syndrome NIH 0.03
D018352 Coronavirus Infections NIH 0.03

Correlated HPO Terms (8)

Name (Synonyms) Correlation
HP:0100615 Ovarian neoplasm HPO 0.58
HP:0010784 Uterine neoplasm HPO 0.58
HP:0100650 Vaginal neoplasm HPO 0.58
HP:0030416 Vulvar neoplasm HPO 0.58
HP:0030079 Cervix cancer HPO 0.58
HP:0003002 Breast carcinoma HPO 0.58
HP:0001928 Abnormality of coagulation HPO 0.29
HP:0002664 Neoplasm HPO 0.17

There are 3 clinical trials

Clinical Trials

1 The Results of COVID 19 Treatment: A Real-life Experience on Patients With COVID 19

COVID 19 treatment using Chloroquine with or without Azithromycin, Faviprevir, Nitazoxanide, Ivermectin.

NCT04345419 COVID Drug: Chloroquine Drug: Favipiravir Drug: Nitazoxanide Drug: Ivermectin Drug: Niclosamide Drug: Other drugs

Primary Outcomes

Description: the estimated number of patients with decreased viral load

Measure: Number of patients with decreased viral load

Time: 6 months

2 Clinical Study Evaluating the Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment

Efficacy of Ivermectin and Nitazoxanide in COVID-19 treatment

NCT04351347 COVID Drug: Chloroquine Drug: Nitazoxanide Drug: Ivermectin

Primary Outcomes

Description: Number of patients with virological cure

Measure: Number of patients with virological cure

Time: 6 months

3 Novel Treatment Regimens in Treatment of COVID-19

Azithromycin has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to be used for Coronavirus disease 2019.

NCT04382846 COVID Corona Virus Infection Drug: Nitazoxanide Drug: Ivermectin Drug: Chloroquine Drug: Azithromycin
MeSH:Coronavirus Infections Severe Acute Respiratory Syndrome

Primary Outcomes

Description: the number of patients with virological cure

Measure: Number of patients with virological cure

Time: 6 months

No related HPO nodes (Using clinical trials)